Home > Insider Trading > Filing (0001127602-23-022036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1757584	David James Clark	One Cvs Drive Woonsocket RI 02895	Svp, Cont & Chief Acct Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-08-03	2,631	$74.79	27,826	No	4	S	Direct
Common Stock	Disposition	2023-08-03	23,128	$74.94	4,698	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	8,882	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	9,050	9,050	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	7,513	7,513	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	24,240	24,240	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	17,157	17,157	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	12,094	12,094	Direct
Common Stock	Stock Option	$101.09	2023-04-01	2032-04-01	6,756	6,756	Direct
Common Stock	Stock Option	$74.31	2024-04-01	2033-04-01	9,649	9,649	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-04-03	9,050	9,050	Direct
2025-04-01	7,513	7,513	Direct
2029-04-01	24,240	24,240	Direct
2030-04-01	17,157	17,157	Direct
2031-04-01	12,094	12,094	Direct
2032-04-01	6,756	6,756	Direct
2033-04-01	9,649	9,649	Direct

Footnotes

Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share.
Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share.
Options became exercisable in four equal annual installments beginning on 4/3/2018.
Options became exercisable in four equal annual installments, commencing 4/1/2019.
Options became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Options became exercisable in four equal annual installments, commencing 4/1/2021.
Option became exercisable in four equal annual installments, commencing 4/1/2022.
Option became exercisable in four equal installments, commencing 4/1/2023.
Option becomes exercisable in four equal annual installments, commencing 4/1/2024.